chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a licensed practical nurse and refers to unspecified patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB (lot # M000442, expiry date: 31-MAR-2018, dose and route of administration were not reported). No symptoms were reported. Administered doses of vaccines experienced the temperature excursion of 32 degrees Fahrenheit for 15 minutes and 31 degrees Fahrenheit for 15 minutes. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Follow-up information received from the licensed practical nurse on 28-APR-2017 refers to a 9-week-old patient of unknown gender. On 15-AUG-2016, the patient received an improperly stored dose of RECOMBIVAX HB (lot # M000442, expiry date: 31-MAR-2018, dose and route of administration were not reported). Additional information has been requested. Sender's Comments: US-009507513-1608USA012908: US-009507513-1608USA012794: US-009507513-1705USA004894: US-009507513-1705USA004895: US-009507513-1705USA004896: US-009507513-1705USA004897: US-009507513-1705USA004898: US-009507513-1705USA004899: US-009507513-1705USA004893: US-009507513-1705USA004892: US-009507513-1705USA004890: US-009507513-1705USA004889: US-009507513-1705USA004888: US-009507513-1705USA004887: US-009507513-1705USA004891: US-009507513-1705USA005004: US-009507513-1705USA005005: US-009507513-1705USA005006: US-009507513-1705USA005007: US-009507513-1705USA004976: US-009507513-1705USA004977: US-009507513-1705USA004978: US-009507513-1705USA004979: US-009507513-1705USA004980: US-009507513-1705USA004981: US-009507513-1705USA004982: US-009507513-1705USA004983: US-009507513-1705USA004984: US-009507513-1705USA004985: US-009507513-1705USA004942: US-009507513-1705USA004944: US-009507513-1705USA004945: US-009507513-1705USA004947: US-009507513-1705USA004948: US-009507513-1705USA004949: US-009507513-1705USA004950: US-009507513-1705USA004951: US-009507513-1705USA004952: US-009507513-1705USA004953: US-009507513-1705USA004954: US-009507513-1705USA004955: US-009507513-1705USA004956: US-009507513-1705USA004957: US-009507513-1705USA004958: US-009507513-1705USA004959: US-009507513-1705USA004960: US-009507513-1705USA004961: US-009507513-1705USA004962: US-009507513-1705USA004963: US-009507513-1705USA004964: US-009507513-1705USA004965: US-009507513-1705USA004966: US-009507513-1705USA004967: US-009507513-1705USA004968: US-009507513-1705USA004969: US-009507513-1705USA004975: US-009507513-1705USA004974: US-009507513-1705USA004973: US-009507513-1705USA004972: US-009507513-1705USA004971: US-009507513-1705USA004970: US-009507513-1705USA004946: MERCK 1608USA012916: Mfr number.
Every time I get the flu shot I get sick; Initial information received on 28-Dec-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-helath care professional.  This case involves a patient of unknown demographics who every time get the flu shot, get sick after receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It is unknown if the patient had any medical history, concomitant disease or risk factor.   On an unknown date, the patient received a unknown dose of suspect  INFLUENZA VACCINE produced by unknown manufacturer (lot number, expiry date, strength, formulation, route was unknown) in unknown administration site for Flu(influenza). Information regarding batch number details has been requested.  On an unknown date the patient reported that every time i get the flu shot i get sick (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  It is unknown if there were lab data/results available.   Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event (Every time I get the flu shot I get sick).  Outcome: Unknown
nausea, vomiting, insomnia, runny  nose--started 1:00 AM 21.  /Left arm sore at injection site.  Still have runny nose
COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment information was not provided.  Reported that a family got a COVID-19 vaccine (possible Moderna, but uncertain) and had COVID-19 4 months after. Reporter had very limited information and did not know who many patients were involved. Only gave initials of one patient who is on theirs 50s (age unknown).  Company comment: This is a spontaneous case concerning a  male patient of an unknown age with no medical history reported, who experienced unexpected events of COVID 19. The event occurred on an unknown date after a dose of mRNA-1273 vaccine. It was reported that a family got a COVID-19 vaccine (possible Moderna, but uncertain) and had COVID-19 4 months after. Reporter had very limited information and did not know who many patients were involved. Only gave initials of one patient who is on theirs 50s (age unknown). The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case concerning a  male patient of an unknown age with no medical history reported, who experienced unexpected events of COVID 19 (AESI). The event occurred on an unknown date after a dose of mRNA-1273 vaccine. It was reported that a family got a COVID-19 vaccine (possible Moderna, but uncertain) and had COVID-19 4 months after. Reporter had very limited information and did not know who many patients were involved. Only gave initials of one patient who is on theirs 50s (age unknown). The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
54 yo F with PMHX of RA, fibromyalgia, depression, hypertriglyceridemia who presents for worsening cough and fever. States she went to a wedding last Saturday (10/23) and started feeling symptoms on Tuesday night
Experienced chest pain on 11/30/2017, two days after vaccination, that was unbearable and had to call ER. Ended up with Pericarditis, left lung fluid build up and took about 2 months to slowly recover from the severe chest pain.
This spontaneous report was received from a physician and a practice manager and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 18-JAN-2016, the patient was vaccinated with improperly stored dose of PNEUMOVAX 23 0.5 ml prefilled syringe (lot # L024132, expiration date: 21-JAN-2017; dose and route were not provided). The vaccine underwent a temperature excursion of the lowest recorded temperature of 34 degrees Fahrenheit for 240 hours. The vaccine was stored in a refrigerator. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Within the last week, in September 2014, the patient was inadvertently vaccinated with a dose of ZOSTAVAX five days after the expiration date (expiration date in September 2014). No adverse effects reported. Additional information is not expected because there is no reporter's contact information provided.
pt recvd vax;had coughing/v spell w/ prolonged apneic spell;while sleeping became stiff;head/eyes rolled back;color remained pink;to er then hosp,stable condition;chest x-ray,cultures(WNL);uneventful recovery;discharged x 2 days on 5dec;
Narrative:  She has a PMH significant for migraines (being treated by a neurologist) and experienced a migraine after the initial vaccination. This started about 5 minutes afterwards and lasted for less than 10 minutes. The migraine sx were typical for her. She followed up with her neurologist, who did not change her current maintenance rx, but did change her prn to ubrelvy (urbrogepant). Her neurologist otherwise said no changes and advised her to proceed with the 2nd vaccination.
Roughly 15-30 minutes after vaccination, patient experience leg swelling/fluid retention. Legs were visibly swollen and painful/difficult to walk on for the next 2-3 days. Patient also experienced some breathing difficulty, describing it as an itchy/irritated throat ("it just felt funny").  Patient took no intervention, and adverse effects resolved on after 2-3 days.
she had a pumping, like an adrenaline rush, just her racing heart beat for 15 Sec; felt giddy like a histamine reaction; slight headache; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (she had a pumping, like an adrenaline rush, just her racing heart beat for 15 Sec), DIZZINESS (felt giddy like a histamine reaction) and HEADACHE (slight headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0311.20A) for COVID-19 vaccination.     The patient's past medical history included Blood pressure, Hypothyroidism and Heart rate high (she had had this in the past, probably a year ago). Concurrent medical conditions included Penicillin allergy, Overweight and Arthritis.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced PALPITATIONS (she had a pumping, like an adrenaline rush, just her racing heart beat for 15 Sec), DIZZINESS (felt giddy like a histamine reaction) and HEADACHE (slight headache). On 19-Feb-2021, PALPITATIONS (she had a pumping, like an adrenaline rush, just her racing heart beat for 15 Sec), DIZZINESS (felt giddy like a histamine reaction) and HEADACHE (slight headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications was reported Treatment information was not provided
At 13:47 pm, 9/24/2022, after patient received vaccination, patient got quickly and slightly stumbled to the other side of room. Three nurses rushed to his side and helped patient lay down on the floor in a controlled and safe manner. Patient had rapid breathing, but was Alert oriented x3. Patient was heard saying "this happens all the time". When asked when was the last time he ate, his answer was "last night", meaning 9/23/2022.  After patient's vitals were obtained, his vitals presented within normal range, the patient was assisted to a sitting position  and drank juice. Five minutes later, patient was moved to the emergency section, lay down on the cot and closely monitored by primary nurse. Patient's partner was brought to his side. 14:13, Patient was drinking juice, water and crackers and demonstrated improved appearance and cognition. 14:30, B/P 114/78, o2 sat 98 room air. 14:30, patient safely ambulated out of clinic with partner.
p/vax pt exp a mild case of chickenpox w/small lesions & a fever of 103;pt sought unspecified medical attention;
arm pain immediately following vaccination that extends down the entire arm, unable to lift arm up all the way. Described vaccination site and said he took pictures before removing band-aid for documentation, it sounds like the vaccine may have been administered too high on the arm
patient came to pharmacy to receive first Pfizer pediatric. Instead, Engerix B was given. The 20mcg was handled like pediatric Pfizer (diluted with 1.3 ml NaCl and then given 0.2ml). Parent was notified as soon as the error was discovered (same day). Called the parent the next day and the mother said that child was not having an adverse reaction. Also called to patient's doctor and spoke with the nurse. The nurse said she did  not think the doctor would need to see the patient because of the very small dose that was given, but that she would notify the doctor of the situation. I asked the nurse to call me and the parent back, the doctor did not ever call md back again.
Moderna vaccine (NDC 80777-0273-98) lot # 039D21A + GTIN 00380777273983 was administered after the beyond date of 10/23/2021.  Contacted Manufacturer Moderna = no need to repeat.
Itching on left arm. Red swollen hard lump. On Monday Jan 11. Itching on Tuesday red on arm Swelling gone still itching Wed. Itching Thursday itching Friday red  itching less
Ended up in the emergency room; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of ADVERSE EVENT (Ended up in the emergency room) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Ended up in the emergency room). At the time of the report, ADVERSE EVENT (Ended up in the emergency room) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Broke out in rash covering my back, neck, chest, and shoulders. Rash resembled red circular rings, ranging in sizes up to about 1 inch in diameter, splattered all over said area. The Rash was somewhat itchy. Doctor prescribed antihistamines and cortozone creams. Rash started on the back and back of neck and shoulders then as days went on it progressed to chest, front of neck and front shoulders. Other symptoms since the vaccine include headache and minor shakey hands. As of today, 8/24/21, rash has not fully resolved.
Neck pain and stiffness, headache unlike any previous headache, fever, myalgia, somnolence, mental confusion, anorexia, eye pain, photophobia:   worst during the first 24 hours after vaccination, but ongoing to present. Feels like meningitis symptoms.
Arm pain; Extreme fatigue; Muscle pain; Joint pain; This case was reported by a consumer and described the occurrence of pain in arm in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd October 2019, the patient received the 1st dose of Shingrix. In October 2019, less than a week after receiving Shingrix, the patient experienced pain in arm, fatigue, myalgia and arthralgia. The patient was treated with ibuprofen. On an unknown date, the outcome of the pain in arm was recovered/resolved and the outcome of the fatigue, myalgia and arthralgia were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm, fatigue, myalgia and arthralgia to be related to Shingrix.  Additional details were profidd as follows: On 22nd october, one week ago, the patient received dose of Shingrix. After vaccination the patient had arm pain that subsided. The patient had extreme fatigue, muscle and joint pain which were getting worse after each day with today being the worst so far.
2nd dose 29 days after 1st dose; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 60-year-old female patient who received Herpes zoster (Shingrix) (batch number G955C, expiry date 20th June 2023) for prophylaxis.   Concomitant products included RECOMBINANT VARICELLA ZOSTER VIRUS SURFACE GLYCOPROTEIN E (SHINGRIX).   On 15th April 2022, the patient received the 2nd dose of Shingrix. On 15th April 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.   Additional Information: GSK Receipt Date: 19-Apr-2022 Reporter's comments: The patient received Shingrix after 29 days after the 1st dose. The healthcare professional was aware that this was earlier than the recommended interval schedule. The healthcare professional confirmed that this patient was not immunocompromised. The consent to follow up was given. The healthcare professional provided fax number.  Additional Supportive Information: The patient received 2nd dose of Shingrix earlier than recommended time frame, which led to shortening of interval between vaccine doses.
Diarrhea with blood in stool. Repeated pattern after eating Lacoste within 5 minutes.
pt recv vax in late summer to early fall 1994 & pt fainted & fully recovered w/o tx;
COVID+ 10/14/22 - Vaccination status  - Moderna x4 + bivalent booster BRIEF OVERVIEW: Admission Date: 10/14/2022 Discharge Date: Oct 16, 2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Pyelonephritis Sepsis Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present COVID-19   HOSPITAL COURSE: The patient is a 76 y.o. female who presented today to the ER secondary to flank pain and fever.  Few days ago, she started to complain of dysuria, chills and flank pain.  Yesterday, she called her PCP, had urine sample checked which was positive. She was was started on Bactrim.  Last night, she started to complain of worsening bilateral flank pains together with generalized weakness and developed fever.  She reported having nausea but denied any vomiting, cough/congestion shortness of breath or chest pain.  She did receive COVID 19 vaccine and 3 booster doses.  Imaging did not reveal pyelonephritis or hydronephrosis.  Patient was treated for urinary tract infection.  She was started on IV Rocephin and tolerated this well..  Patient did not require any therapy for COVID-19 infection.  She remained on room air during her stay.  After couple days, patient white blood cell count had normalized and she was afebrile.  She is medically stable for discharge.
10-year-old male with father at his side received 1st dose Pfizer vaccine. Three minutes after vaccination, he vomited a moderate amount of previously ingested food. No bilious, yellowish or hematemesis noted. No other symptoms. Vital signs stable. BP 110/61, P 70, RR 16 and SPO2 100%. Alert and oriented, at usual activity level. He was placed on a stretcher with head elevated. Observed. Reported feeling well. Placed on a chair. Tolerated PO fluids. Discharged home stable. Instructed parent to go to ED for  return or new symptoms. Parent reported he was carsick on the drive coming and nervous prior to vaccination.
Client reports having a headache over left eye about 1 1/2 hours after injection.  Client woke up on 2/9/2021 to a swollen face.  Swelling to both eyes and "bruising" under both eyes.  Client is experiencing light sensitivity.  Continues to have a headache and discomfort over left eye.  Denies respiratory distress and reports no rash.  Recommended follow up with PCP.
Patient was given an immunization that was for the age 4-6 years, which she was to young for. She did not have any adverse reaction to the immunization.
PATIENT STATES SHE FELT LIKE SHE HAD FLU SYMPTOMS AND ARM WAS PAINFUL AND RED
I develop A-fib two weeks after getting my second vaccine. The blood work showed smooth muscle antibody with/reflex to titter. It was positive. It is never suppose to be positive. It was 1:40. It's normal range it show be 1-20.   It could mean that I could have a liver disease for life. My doctor felt that all this is related to the vaccine. So my doctor will repeat lab work in a few months to see if my levels have gone back to normal. My PCP sent me to see a Cardiologist.
Screaming, crying from 3pm - 7:30, not feeding well (breast/bottle), increased sleeping, and still fussy today despite appropriate Acetaminophen dosing every 4 hours
First onset of migraine symptoms including aura within 12 hours of vaccination.  No prior history of this condition.  Reported initially in November, but told no one had heard of such a problem related to the vaccine.  However, it's been over 8 weeks, I'm still suffering from migraines, the pain has radiated down the left side of my body (including numbness and tingling in my left fingers and toes, leg spasms. and shooting pain in left butt cheek). I've been to the ER twice, ophthalmologist, primary physician and neurologist. I was also in a state of incapacitation at the neurologist's office once.  I have no insurance.  I receive some help through facility, but they tell me Pain Management resources are extremely limited.  I have spasms in my leg and I can't control the pain.  I've called facility twice because I've been in crisis mode.  I NEED HELP!  Nobody even knows how to test to insure it's not due to the shot.  Please help me. The pain is excruciating and I don't know where to turn?  In addition, I'm a legal assistant in two law firms in the same legal suit...Well, at least I was.  I was laid off one of my jobs today and I don't know what I'm going to do if I lose the second job?  I just need to rule out everything right now.  How do I get that Done?
Very drowsy on first, second and third day A little bothersome in the shoulder second day A little sore throat for 3 days
Following the integration of the legacy safety adverse event reporting databases, this case has been migrated from the legacy company database into the current safety database for processing follow-up information. As a consequence of this migration, the follow-up CIOMS I or Med Watch report may indicate in the appropriate field that it is an initial report. Information regarding PREVNAR 13 was received from a healthcare professional regarding a patient who experienced cellulitis. The patient received a dose on an unspecified date. The patient experienced a cellulitis like reaction and a low grade fever that lasted a few days. The patient was taken to the Emergency Room and antibiotics and received antibiotics. Cellulitis was diagnosed. Outcome was unknown. No additional information was available at the time of this report. Follow-up (25May2011): New information received from a contactable healthcare professional: The patient recovered. Follow-up attempts completed. No further information expected.
Had high fever of 104.6 night of vaccine with extreme fatigue and chills. Next morning collapsed due to lack of blood to the brain due to dehydration. Doctor said it was a side effect of the side effect (fever) not directly from vaccine. Fully recovered within 48 hours
Patient is fully vaccinated.  COVID + at ED visit on 1/8/2022. Patient states that he began experiencing diffuse, generalized body aches, intermittent subjective fevers and chills, sore throat, and congestion yesterday. He denies any significant shortness of breath or chest pain. Positive for fatigue, nausea.  BP 132/84  | Pulse 65  | Temp 98.2 °F (36.8 °C) (Oral)  | Resp 18  | Ht 185.4 cm (6' 1")  | Wt 104 kg (230 lb)  | SpO2 99%  | BMI 30.34 kg/m² CXR: Patchy airspace opacities at the bilateral lung bases may reflect atelectasis or developing pneumonia. Medications; zofran, toradol. Stable for discharge.  Referred for monoclonal antiboldy influsion.
Starting 3 hours after and throughout the entire following day I experienced chills, fatigue, and body aches with a constant urge to cough. 2 days after I was experiencing shortness of breath and a constant urge to cough.
Much pain in left arm, swollen as well, within 12hrs of shot. And high fever after 15-16hrs of shot, highest temp. was 103.7F. Took Tylenol for the pain and fever. The arm pain and intermittent fever was for total 24hrs.